The white-berry mistletoe has been used as a medicinal plant since ancient times. For 100 years it has also been proven in integrative oncology.

It blooms in winter, grows spherically on trees, and does not adjust its position to the sun: The "anti-tendency" of mistletoe against natural laws demonstrates similarities to the growth of tumors. Hence, its healing potential for cancer therapy was recognized and the Dutch physican Dr. Ita Wegman developed the first injectable mistletoe preparation in 1917. Today mistletoe therapy is established as a complementary form of therapy in oncology.

Studies show that mistletoe therapy has a positive effect on the patient’s immune system and quality of life and can improve tolerance of standard therapies – such as chemotherapy – without decreasing their efficacy.

Mistletoe cancer therapy is appropriate for almost all tumor diseases. You can start using mistletoe at any time – before or after surgery, as well as before, during, or after radiation, chemo-, hormonal, or antibody therapies.

You need a doctor for prescribing, initiating and monitoring your mistletoe therapy. The mistletoe extract is injected subcutaneously (under the skin). After briefing by your doctor, you can administer the mistletoe injection yourself, or ask a caregiver to do it. If you have any questions or look for doctors familiar with mistletoe therapy, please contact our medical advice.